- Home
- ARQT vs WT Comparison
ARQT vs WT Comparison
Compare ARQT & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | WT |
|---|---|---|
| Founded | 2016 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ARQT | WT |
|---|---|---|
| Price | $27.81 | $19.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $34.00 | $17.67 |
| AVG Volume (30 Days) | 1.3M | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.74% |
| EPS Growth | 88.79 | ★ 127.27 |
| EPS | ★ N/A | N/A |
| Revenue | $376,072,000.00 | ★ $493,753,000.00 |
| Revenue This Year | $34.85 | $35.04 |
| Revenue Next Year | $29.39 | $8.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 91.34 | 15.43 |
| 52 Week Low | $13.70 | $10.69 |
| 52 Week High | $31.77 | $21.23 |
Technical Indicators
Market Signals| Indicator | ARQT | WT |
|---|---|---|
| Relative Strength Index (RSI) | 57.39 | 51.56 |
| Support Level | $27.63 | $16.06 |
| Resistance Level | $29.47 | $19.71 |
| Average True Range (ATR) | 1.17 | 0.76 |
| MACD | -0.16 | -0.05 |
| Stochastic Oscillator | 48.04 | 24.12 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.